Andrew Dick is a panelist for this discussion of best practices associated with employing economists during an agency’s review of a pending merger and how the economist’s role changes if the merger is challenged. For more information, click here.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...
